BioLineRx Ltd.
BLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498403
No open-market purchases or sales by BioLineRx Ltd. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $206.7K in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding BioLineRx Ltd. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 29 | 30 | +1 |
| Shares | 4.82M | 1.42M | −3.40M (−70.4%) |
| Value | $13.5M | $4.01M | −$9.44M (−70.2%) |
New holders (7)
Institutions that held BioLineRx Ltd. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 45,097 | $127.0K | 0.00% |
| ACT Capital Management, LLC | 27,500 | $78.0K | 0.04% |
| Geneos Wealth Management Inc. | 17,450 | $58.0K | 0.00% |
| Virtu Financial LLC | 16,578 | $47.0K | 0.00% |
| Millennium Management LLC | 14,922 | $42.0K | 0.00% |
| Thomasville National Bank | 10,000 | $28.0K | 0.00% |
| FMR LLC | 1 | $0 | 0.00% |
Sold out (6)
Institutions that held BioLineRx Ltd. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sio Capital Management, LLC | 2,741,776 | $7.65M |
| Silverarc Capital Management, LLC | 200,000 | $558.0K |
| Psagot Investment House Ltd. | 117,000 | $326.0K |
| Schonfeld Strategic Advisors LLC | 76,500 | $213.0K |
| Goldman Sachs Group Inc | 16,621 | $46.0K |
| Raymond James & Associates | 12,609 | $35.0K |